Contact information
Research groups
Rachel Roberts
Recent publications
-
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Journal article
Folegatti PM. et al, (2020), The Lancet. Infectious diseases, 20, 816 - 826
-
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
-
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
Journal article
Venkatraman N. et al, (2019), The Journal of Infectious Diseases, 219, 1187 - 1197
-
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 33 - 33
-
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Journal article
Tiono AB. et al, (2018), PLOS ONE, 13, e0208328 - e0208328